ABL Europe

Rockville, United States Founded: 1961 • Age: 65 yrs Acquired By Oxford BioMedica
Preclinical development services are provided by ABL to biotechnology clients.

About ABL Europe

ABL Europe is a Healthcare company based in Rockville (United States) founded in 1961, and was acquired by Oxford BioMedica in December 2023. Preclinical development services are provided by ABL to biotechnology clients. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Celgene, Syneos Health and Medelis WCCT Global; 2 of its 3 listed competitors have raised funding.

Company details

ABL was established in 1961 and is based in Rockville, United States. Preclinical development services are delivered by the company within the biotechnology and pharmaceutical sectors. Operations encompass support for drug discovery, safety assessments, and early-stage testing. Expertise is applied across various therapeutic areas, with a domain indicating European outreach. Services are tailored for research organizations seeking regulatory-compliant preclinical solutions.

Key Metrics

Investors in ABL Europe

ABL Europe has secured backing from 1 investor. Prominent investors backing the company include OXB.

All
InvestorDescriptionFounded YearDomainLocation
Gene therapies for multiple diseases are developed via lentiviral systems.
1995oxb.comOxford, United Kingdom
Premium access

Investor details for ABL Europe

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of ABL Europe

2 dated milestones of ABL Europe across 62 years, from founding to its latest funding, stage changes and deals.

  1. Founded ABL Europe is founded.
  2. Exit Acquired by Oxford BioMedica.

Competitors of ABL Europe

ABL Europe has 3 listed competitors in our database, 2 of them funded. They include Celgene, Syneos Health and Medelis WCCT Global.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
celgene.com1986Summit, United States$45M4,891
Therapies for cancer and inflammatory diseases are developed.
syneoshealth.com1984Raleigh, United States29,395
CRO clinical development services are provided by Syneos Health.
wcct.com1998Cypress, United States$17M229
Full-service CRO expertise in influenza and oncology research is offered.
Premium access

Detailed competitors of ABL Europe

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as ABL Europe (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about ABL Europe

ABL Europe was founded in 1961.

ABL Europe is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.

ABL was established in 1961 and is based in Rockville, United States. Preclinical development services are delivered by the company within the biotechnology and pharmaceutical sectors. Operations encompass support for drug discovery, safety assessments, and early-stage testing. Expertise is applied across various therapeutic areas, with a domain indicating European outreach. Services are tailored for research organizations seeking regulatory-compliant preclinical solutions.

ABL Europe's top competitors include Syneos Health, Medelis WCCT Global and Celgene.

ABL Europe has 1 investor. Key investors include OXB.

Yes. ABL Europe was acquired by Oxford BioMedica in December 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available